Abstract
A new dimeric prenylated quinolone alkaloid, named 2,11-didemethoxy-vepridimerine A, was isolated from the root bark of Zanthoxylum rhetsa, together with twelve known compounds. The structure of the new compound was elucidated on the basis of spectroscopic investigations (NMR and Mass). The interaction of the isolated compounds with the main protease of SARS-CoV-2 (Mpro) was evaluated using molecular docking followed by MD simulations. The result suggests that 2,11-didemethoxy-vepridimerine A, the new compound, has the highest negative binding affinity against the Mpro with a free energy of binding of −8.5 Kcal/mol, indicating interaction with the Mpro. This interaction was further validated by 100 ns MD simulation. This implies that the isolated new compound, which can be employed as a lead compound for an Mpro-targeting drug discovery program, may be able to block the action of Mpro.
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference34 articles.
1. Natural products may interfere with SARS-CoV-2 attachment to the host cell;J. Biomol. Struct. Dyn.,2021
2. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies;Int. J. Antimicrob. Agents,2020
3. Thomford, N.E., Senthebane, D.A., Rowe, A., Munro, D., Maroyi, A., and Dzobo, K. (2018). Natural products for drug discovery in the 21st century: Innovations for novel drug discovery. Int. J. Mol. Sci., 19.
4. Computer-aided drug design of bioactive natural products;Curr. Top. Med. Chem.,2015
5. Public databases of plant natural products for computational drug discovery;Curr. Comput. Aided Drug Des.,2014